US2009186850A1PendingUtilityA1
Peritoneal dialysis method
Est. expiryNov 21, 2022(expired)· nominal 20-yr term from priority
A61P 43/00A61P 7/08A61P 29/00A61M 1/287A61M 1/28A61K 33/00A61K 45/06A61P 13/12A61K 31/7052A61K 31/7076
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A peritoneal dialysate containing adenosine triphosphate or a salt thereof, and a peritoneal dialysis method using the dialysate. The peritoneal dialysate is safe and causes less peritoneal injuries even when employed in peritoneal dialysis over a long period of time.
Claims
exact text as granted — not AI-modified1 .- 20 . (canceled)
21 . A composition comprising water, glucose, electrolytes, and adenosine triphosphate or a salt thereof in a form suitable for use as a pertioneal dialysate.
22 . The composition of claim 21 , which has an osmotic pressure of 300 to 700 mOsm/L.
23 . The composition of claim 21 , which contains glucose in at a concentration of 1,000 to 4,000 mg/dL.
24 . The composition of claim 21 , which contains glucose in at a concentration of 1,200 to 3,600 mg/dL.
25 . The composition of claim 21 , which contains Na + , Ca 2+ , Mg 2+ and Cl − as electrolytes.
26 . The composition of claim 21 , which contains as electrolytes 100-200 mEq/L Na + , 4-5 mEq/L Ca 2+ , 1-2 mEq/L Mg 2+ and 80-120 mEq/L Cl − .
27 . The composition of claim 21 , which contains 10-5,000 μM ATP or a salt thereof.
28 . The composition of claim 21 , which contains 50-2,000 μM ATP or a salt thereof.
29 . The composition of claim 21 , further comprising at least one organic acid in an amount ranging from 30-50 mEq/L.
30 . The composition of claim 21 , further comprising lactic acid in an amount ranging from 30-50 mEq/L.
31 . The composition of claim 21 , which has an osmotic pressure of 300 to 700 mOsm/L, and which contains:
1,000 to 4,000 mg/dL glucose, 100-200 mEq/L Na + , 4-5 mEq/L Ca 2+ , 1-2 mEq/L Mg 2+ and 80-120 mEq/L Cl − as electrolytes, 10-5,000 μM ATP or a salt thereof, and optionally 30-50 mEq/L of at least one organic acid.
32 . A peritoneal dialysis method comprising administering into the peritoneum of a subject in need thereof an effective amount of the composition of claim 21 .
33 . The method of claim 32 , wherein the composition is administered intraperitoneally via a catheter implanted in the peritoneal cavity.
34 . The method of claim 32 , further comprising administering a dialysate containing a level of glucose above a physiological level of glucose
wherein said dialyzate is administered after administering said composition and wherein said composition contains a physiological level of glucose ranging from 0.08 to 0.16% (w/v).
35 . The method of claim 32 , wherein the subject has a renal disease.
36 . The method of claim 32 , wherein said subject has cell injuries caused by exposure to high levels of sugar.
37 . The method of claim 32 , wherein said subject has peritoneal mesothelial cell injuries caused by exposure to high levels of sugar.
38 . The method of claim 32 , wherein said subject has hardening of the peritoneum or peritonitis.
39 . The method of claim 32 , wherein said subject has sclerotic encysted peritonitis or intractable prolonged peritonitis.
40 . A peritoneal dialysis method comprising:
administering into the peritoneum of a subject in need thereof an effective amount of a dialysate comprising water, glucose, electrolytes; and administering a separate amount of adenosine triphosphate or a salt thereof, which is optionally administered orally, intravenously, intramuscularly, or locally.Join the waitlist — get patent alerts
Track US2009186850A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.